Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Quilici

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
JACC. Cardiovascular Interventions|January 25, 2014
Reply: P2Y12-Based platelet function assays should be complemented with cyclooxygenase-dependent testing in framing the therapeutic windows for dual antiplatelet therapyThomas Cuisset, Jacques Quilici, Jean-Louis Bonnet, et al.
JACC. Cardiovascular Interventions|March 10, 2018
Reply: De-Escalation of the P2Y<sub>12</sub> Inhibitor After Acute Coronary Syndromes According to On-Treatment Platelet Reactivity: A Promising Step of Enormous Magnitude That Should Be ExploredPierre Deharo, Laurence Camoin, Jacques Quilici, et al.
International Journal of Cardiology|February 25, 2009
Index of Microcirculatory Resistance: a new effective invasive tool to assess reperfusion after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionThomas Cuisset, Raphael Poyet, Laurent Bali, et al.
International Journal of Cardiology|March 14, 2007
Diagnosis contribution of IVUS in embolic myocardial infarctionThomas Cuisset, Jacques Quilici, Lyassine Nait Saidi, et al.
Journal of the American College of Cardiology|August 23, 2008
Adjusting clopidogrel loading doses according to vasodilator-stimulated phosphoprotein index: on time, too early, or too late?Thomas Cuisset, Corinne Frere, Jacques Quilici, et al.
Presse Medicale (Paris, France : 1983)|March 23, 2011
[Coronary thrombosis with normal epicardial coronary arteries]Philippe Paule, Thomas Cuisset, Jean-Marie Gil, et al.
International Journal of Cardiology|January 22, 2013
Predictors of long-term high on-treatment platelet reactivity in clopidogrel-treated patients undergoing coronary stenting for acute coronary syndromeThomas Cuisset, Jacques Quilici, Pierre Emmanuel Morange, et al.
Acta Cardiologica|February 10, 2011
Coronary wall characteristics after myocardial infarction without significant coronary angiographic lesion: an intravascular ultrasound studyRaphaël Poyet, Thomas Cuisset, Laurent Bali, et al.
International Journal of Cardiology|August 19, 2008
Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?Thomas Cuisset, Corinne Frere, Jacques Quilici, et al.
International Journal of Cardiology|April 11, 2009
An unusual "winter case" of myocarditisAurore Leroy, Thomas Cuisset, Jacques Quilici, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
JACC. Cardiovascular Interventions|January 25, 2014
Reply: P2Y12-Based platelet function assays should be complemented with cyclooxygenase-dependent testing in framing the therapeutic windows for dual antiplatelet therapyThomas Cuisset, Jacques Quilici, Jean-Louis Bonnet, et al.
JACC. Cardiovascular Interventions|March 10, 2018
Reply: De-Escalation of the P2Y<sub>12</sub> Inhibitor After Acute Coronary Syndromes According to On-Treatment Platelet Reactivity: A Promising Step of Enormous Magnitude That Should Be ExploredPierre Deharo, Laurence Camoin, Jacques Quilici, et al.
International Journal of Cardiology|February 25, 2009
Index of Microcirculatory Resistance: a new effective invasive tool to assess reperfusion after primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionThomas Cuisset, Raphael Poyet, Laurent Bali, et al.
International Journal of Cardiology|March 14, 2007
Diagnosis contribution of IVUS in embolic myocardial infarctionThomas Cuisset, Jacques Quilici, Lyassine Nait Saidi, et al.
Journal of the American College of Cardiology|August 23, 2008
Adjusting clopidogrel loading doses according to vasodilator-stimulated phosphoprotein index: on time, too early, or too late?Thomas Cuisset, Corinne Frere, Jacques Quilici, et al.
Presse Medicale (Paris, France : 1983)|March 23, 2011
[Coronary thrombosis with normal epicardial coronary arteries]Philippe Paule, Thomas Cuisset, Jean-Marie Gil, et al.
International Journal of Cardiology|January 22, 2013
Predictors of long-term high on-treatment platelet reactivity in clopidogrel-treated patients undergoing coronary stenting for acute coronary syndromeThomas Cuisset, Jacques Quilici, Pierre Emmanuel Morange, et al.
Acta Cardiologica|February 10, 2011
Coronary wall characteristics after myocardial infarction without significant coronary angiographic lesion: an intravascular ultrasound studyRaphaël Poyet, Thomas Cuisset, Laurent Bali, et al.
International Journal of Cardiology|August 19, 2008
Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?Thomas Cuisset, Corinne Frere, Jacques Quilici, et al.
International Journal of Cardiology|April 11, 2009
An unusual "winter case" of myocarditisAurore Leroy, Thomas Cuisset, Jacques Quilici, et al.
Pageof 8